Dasatinib inhibits mammary tumour development in a genetically engineered mouse model. - Wikidata - wikimedia - TriplyDB

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

http://www.wikidata.org/entity/Q39160945

about

Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer.The dynamics of Rho GTPase signaling and implications for targeting cancer and the tumor microenvironment.Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer.MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Integrin signalling regulates YAP and TAZ to control skin homeostasis.Mouse models of metastasis: progress and prospects.The 8th international symposium on the breast: Using next-generation science to understand the normal breast and the development of breast cancer- conference report.

P2860

Q26765201-FAD9493F-621F-4AE7-BA31-65FA63407D6F Q30679405-ED23FF90-D6D3-4136-9F70-007FE5B6810C Q34025103-7FB33C13-0841-48BD-AE27-F94E4FC4EB80 Q34135475-C37B0BB7-8846-4D5D-8505-540C1271E4E5 Q34323926-E016173C-9341-4205-9915-1D8E7719FAD5 Q36147572-F82B1667-65DD-4557-B523-BF4674DBF35D Q36627745-8C39B935-B0FC-4AB7-9C77-3F9F32E1D882 Q37487789-A533AA8E-6D8D-4463-AAA6-038A6401693B Q38785275-7D5733CF-B7C8-4362-A4B3-8BEB0ADD7297 Q41664785-ACAA29B4-72E7-4437-A44E-A0CCC5CD8328 Q46647592-562B35F8-0F22-45B3-AD71-265815A1067A

P2860

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

http://www.wikidata.org/entity/Q39160945

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@en

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@nl

type

label

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@en

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@nl

prefLabel

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@en

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@nl

P1433

Q39160945-A1FCAF43-960D-452B-8004-DCBF5E029556

P1476

Q39160945-E7AA8089-D32C-4539-8B26-75C69083B614

P2093

Q39160945-37DD3E75-C298-4AE1-938F-C3261E5706C1

Q39160945-4A7EA9EA-717A-4A6F-84BA-AD8F22CA687F

Q39160945-71D7F04F-8917-4B11-86A4-5D8D2A973063

Q39160945-A47EC5C5-D580-4094-A3BA-7572CD0D6BC2

Q39160945-E07B9820-CC56-48F1-939B-30A7579EDD99

Q39160945-E97580A2-D853-417C-8710-D74BF8FAE09D

Q39160945-F13920AD-88B9-4366-B5E2-36F895980615

P2860

Q39160945-005C1394-197B-4ED2-8C34-AB2E32809075

Q39160945-018D3FB0-64AA-44CB-9268-E0F6AC713805

Q39160945-0273E66E-02A4-4AE5-A6DC-51A3E844B713

Q39160945-04CA2A2C-9D49-415A-B975-DE0286754C81

Q39160945-0FA927CF-E5C6-41B7-BE14-98EFD5B690C9

Q39160945-106F9708-7262-4374-900E-38AC8D160A6E

Q39160945-1D8A7316-B1C0-4D72-B6C6-26631741EC53

Q39160945-1E684FBA-E16D-42FF-A5D6-CB0C25B7A5CF

Q39160945-22EA86C7-0AEC-4577-800C-6F28D780CEC1

Q39160945-305699F3-3B48-41FE-B1FF-4BF3FC1FFF83

P304

Q39160945-52769A75-8270-469C-81B6-EE96DE5F02EF

P31

Q39160945-3203D155-8B71-423D-8F49-6FC1BFFF4869

P356

Q39160945-7FEA6265-AAF1-47CE-B792-BAE1B839F883

P433

Q39160945-EA99B4FB-DB57-45E8-8B77-3284D0B9A077

P478

Q39160945-7BD30672-B487-4042-A8C2-2E7468BC7587

P50

Q39160945-1B747B46-C0B4-4B53-B9ED-A49FAD6F0FBF

Q39160945-9E3B5369-265D-45C5-8519-17B26AB52606

Q39160945-C389FB0C-D40C-4D88-B6E5-66DC28326EBD

P577

Q39160945-DF48FC6D-83D6-47FF-B78D-40F3DE99E8DE

P698

Q39160945-82598494-A297-4780-9A12-B7006E15F153

P356

P1433

The Journal of Pathology

P1476

Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.

@en

P2093

Barry Gusterson

http://www.w3.org/2001/XMLSchema#string

Helen Creedon

http://www.w3.org/2001/XMLSchema#string

Hitesh Patel

http://www.w3.org/2001/XMLSchema#string

Saadia A Karim

http://www.w3.org/2001/XMLSchema#string

Thomas Rj Evans

http://www.w3.org/2001/XMLSchema#string

Valerie G Brunton

http://www.w3.org/2001/XMLSchema#string

William J Muller

http://www.w3.org/2001/XMLSchema#string

P2860

Src family kinases in tumor progression and metastasis

Newest findings on the oldest oncogene; how activated src does it

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Significance of ER-Src axis in hormonal therapy resistance

Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects

c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.

Involvement of pp60c-src with two major signaling pathways in human breast cancer.

Src family kinases and HER2 interactions in human breast cancer cell growth and survival.

c-Src and cooperating partners in human cancer.

Src family kinases, key regulators of signal transduction.

P304

430-440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4202

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

230

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer P. Morton

Neil O Carragher

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23616343

http://www.w3.org/2001/XMLSchema#string